{"id":7038,"date":"2018-06-25T09:29:53","date_gmt":"2018-06-25T09:29:53","guid":{"rendered":"http:\/\/www.sib.it\/?p=7038"},"modified":"2019-07-18T10:36:24","modified_gmt":"2019-07-18T10:36:24","slug":"sibprima-june-2018-patentability-of-antibodies-for-therapeutic-use-proposed-spc-waiver-italy-implements-eu-directive-trade-secrets-trademarks-registered-bad-faith","status":"publish","type":"post","link":"https:\/\/www.sib.it\/en\/newsletter\/sibprima-june-2018\/","title":{"rendered":"SIBprima June 2018 &#8211; Patenting antibodies for therapeutic use &#8211; Proposed SPC waiver &#8211; Italy implements trade secrets Directive"},"content":{"rendered":"<p><\/p>\n<table border=\"0 !important\" width=\"676\">\n<tbody>\n<tr>\n<td style=\"border-color: #fafafa;\" colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\" colspan=\"2\"><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\" colspan=\"2\"><img class=\"wp-image-7040 size-full alignleft\" title=\"Patenting antibodies for therapeutic use in Europe\" src=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina_red.2.jpg\" alt=\"Patenting antibodies for therapeutic use in Europe\" width=\"650\" height=\"450\" srcset=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina_red.2.jpg 650w, https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina_red.2-300x208.jpg 300w\" sizes=\"(max-width: 650px) 100vw, 650px\" \/><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa; width: 676px;\" colspan=\"2\"><span style=\"color: #bd1111;\"><strong>EUROPEAN PATENTS &#8211; CASE LAW<br \/>\n<\/strong><\/span><\/p>\n<h2><span style=\"color: #000000;\"><a href=\"https:\/\/www.sib.it\/en\/articles\/patentability-of-antibodies-for-therapeutic-use-in-europe-by-claudio-germinario-et-al\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">When are antibodies for therapeutic use patentable in Europe?<\/span><\/a><\/span><\/h2>\n<p><em><span style=\"color: #000000;\">An article co-authored by our partner Claudio Germinario, published in May 2018 by Nature Biotechnology, explains clearly, schematically and in practical terms the general guidelines on the patentability in Europe of inventions arising from research in the field of poly- and mono-clonal antibodies. (<a href=\"https:\/\/www.sib.it\/en\/articles\/patentability-of-antibodies-for-therapeutic-use-in-europe-by-claudio-germinario-et-al\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">more<\/span><\/a>) <\/span><\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\"><span style=\"color: #bd1111;\"><strong>EUROPEAN UNION &#8211; LEGISLATION UPDATE<\/strong><\/span><\/p>\n<h3><a href=\"https:\/\/www.sib.it\/en\/flash-news\/european-commission-proposes-spc-waiver\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">European Commission proposes SPC waiver<\/span><\/a><\/h3>\n<p><em>The European Commission has proposed the introduction of an SPC waiver aiming to make European Union-based generic and biosimilar manufacturers more competitive on the global market; there is concern that the changing patent protection rules for medicinal products could hurt Europe\u2019s ability to attract investors in medical and pharma research. (<span style=\"color: #000000;\"><a href=\"https:\/\/www.sib.it\/en\/flash-news\/european-commission-proposes-spc-waiver\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">more<\/span><\/a><\/span>) <\/em><\/td>\n<td style=\"border-color: #fafafa;\"><img class=\"alignright size-full wp-image-7011\" src=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg\" alt=\"SPC waiver \" width=\"424\" height=\"283\" srcset=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union.jpg 424w, https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Pharma_European-Union-300x200.jpg 300w\" sizes=\"(max-width: 424px) 100vw, 424px\" \/><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\"><img class=\"wp-image-7077 alignleft\" src=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Secret_S.jpg\" alt=\"\" width=\"288\" height=\"395\" srcset=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Secret_S.jpg 591w, https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Secret_S-218x300.jpg 218w\" sizes=\"(max-width: 288px) 100vw, 288px\" \/><\/td>\n<td style=\"border-color: #fafafa;\"><span style=\"color: #bd1111;\"><strong>ITALY &#8211; LEGISLATION UPDATE<br \/>\n<\/strong><\/span><\/p>\n<h3><span style=\"color: #000000;\"><a href=\"https:\/\/www.sib.it\/en\/flash-news\/italy-implements-eu-directive-on-trade-secrets\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">Italy implements EU Directive on trade secrets<\/span> <\/a><\/span><\/h3>\n<p><em>Legislative Decree No. 63\/2018 came into force on 22 June 2018, implementing into Italian law the European Union Directive No. 943\/2016 on the protection of undisclosed know-how and business information (trade secrets) against their unlawful acquisition, use and disclosure. (<a href=\"https:\/\/www.sib.it\/en\/flash-news\/italy-implements-eu-directive-on-trade-secrets\/\" target=\"_blank\" rel=\"noopener\">more<\/a>) <\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\"><strong><span style=\"color: #bd1111;\">TRADEMARKS IN ITALY &#8211; CASE LAW<\/span><br \/>\n<\/strong><\/p>\n<h3><a href=\"https:\/\/www.sib.it\/en\/flash-news\/italian-supreme-court-rules-on-registration-of-trademarks-in-bad-faith-in-radio-vicenza\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">Italian Supreme Court rules on registration of trademarks in bad faith in Radio Vicenza<\/span> <\/a><\/h3>\n<p><em>The Italian Supreme Court has confirmed that Article 19 (2) of the Industrial Property Code prohibiting registration of trademarks in bad faith does not apply to the registration of abandoned trademarks that have ceased to produce effects. <span style=\"color: #000000;\">(<a href=\"https:\/\/www.sib.it\/en\/flash-news\/italian-supreme-court-rules-on-registration-of-trademarks-in-bad-faith-in-radio-vicenza\/\" target=\"_blank\" rel=\"noopener\"><span style=\"color: #000000;\">more<\/span><\/a>)<\/span><\/em><\/td>\n<td style=\"border-color: #fafafa;\"><span style=\"color: #bd1111;\"><strong><img class=\"alignright size-full wp-image-7001\" src=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Microphone-on-the-air.jpg\" alt=\"Trademark registration in bad faith Italy\" width=\"300\" height=\"400\" srcset=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Microphone-on-the-air.jpg 300w, https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Microphone-on-the-air-225x300.jpg 225w\" sizes=\"(max-width: 300px) 100vw, 300px\" \/><\/strong><\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\"><span style=\"color: #bd1111;\"><strong><img class=\"wp-image-7097 alignleft\" src=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Connect.jpg\" alt=\"\" width=\"311\" height=\"363\" srcset=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Connect.jpg 641w, https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/Connect-257x300.jpg 257w\" sizes=\"(max-width: 311px) 100vw, 311px\" \/><\/strong><\/span><\/td>\n<td style=\"border-color: #fafafa;\"><strong><span style=\"color: #bd1111;\">EVENTS<\/span><br \/>\n<\/strong><\/p>\n<h3>Where can you catch SIB this autumn?<\/h3>\n<p><em>INTA TMAP in Orlando, MARQUES Annual Meeting in Paris, AIPPI World Congress in Cancun&#8230;<\/em><br \/>\n<em><a href=\"https:\/\/www.sib.it\/en\/category\/events\/\" target=\"_blank\" rel=\"noopener\">Find out<\/a> which other events we will be attending.<\/em><\/p>\n<p><em>See you there!<\/em><\/td>\n<\/tr>\n<tr>\n<td style=\"border-color: #fafafa;\"><span style=\"color: #bd1111;\"><strong>RECOGNITIONS<\/strong><\/span><em><em><strong><br \/>\n<\/strong><\/em><\/em><\/p>\n<h3><strong>Did you know?<\/strong><em><strong><br \/>\n<\/strong><\/em><\/h3>\n<p><em>SIB is the only Italian IP firm that has been ranked in Tier 1 for trademark prosecution for 13 years in <\/em>row<em> by the IP Stars &#8211; Managing Intellectual Property World Survey.<\/em><\/p>\n<p><em>Most major international IP surveys rank SIB every year.<\/em><\/p>\n<p><em><a href=\"https:\/\/www.sib.it\/en\/about-us\/recognitions\/\" target=\"_blank\" rel=\"noopener\">Find out which ones<\/a>!<\/em><\/p>\n<p><em><br \/>\n<\/em><\/td>\n<td style=\"border-color: #fafafa;\"><img class=\"alignright wp-image-7099\" src=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/IP-Star-rosette-2018.jpg\" alt=\"\" width=\"278\" height=\"211\" srcset=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/IP-Star-rosette-2018.jpg 661w, https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/IP-Star-rosette-2018-300x228.jpg 300w\" sizes=\"(max-width: 278px) 100vw, 278px\" \/><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>\u200b<\/p>\n<p>&nbsp;<\/p>","protected":false},"excerpt":{"rendered":"<p>EUROPEAN PATENTS &#8211; CASE LAW When are antibodies for therapeutic use patentable in Europe? An article co-authored by our partner Claudio Germinario, published in May 2018 by Nature Biotechnology, explains clearly, schematically and in practical terms the general guidelines on the patentability in Europe of inventions arising from research in the field of poly- and [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":7103,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_mi_skip_tracking":false},"categories":[16],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v18.4.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>SIBprima June 2018 Patentability of antibodies for therapeutic use<\/title>\n<meta name=\"description\" content=\"SIBprima June 2018 - Patentability of antibodies for therapeutic use - Proposed SPC waiver - Italy implements EU Directive on trade secrets\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"SIBprima June 2018 Patentability of antibodies for therapeutic use\" \/>\n<meta property=\"og:description\" content=\"SIBprima June 2018 - Patentability of antibodies for therapeutic use - Proposed SPC waiver - Italy implements EU Directive on trade secrets\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/\" \/>\n<meta property=\"article:published_time\" content=\"2018-06-25T09:29:53+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-07-18T10:36:24+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina-thumb2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"263\" \/>\n\t<meta property=\"og:image:height\" content=\"165\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Laura Ercoli\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.sib.it\/#website\",\"url\":\"https:\/\/www.sib.it\/\",\"name\":\"\",\"description\":\"Intellectual Property since 1882\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.sib.it\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#primaryimage\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina-thumb2.png\",\"contentUrl\":\"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina-thumb2.png\",\"width\":263,\"height\":165},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#webpage\",\"url\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/\",\"name\":\"SIBprima June 2018 Patentability of antibodies for therapeutic use\",\"isPartOf\":{\"@id\":\"https:\/\/www.sib.it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#primaryimage\"},\"datePublished\":\"2018-06-25T09:29:53+00:00\",\"dateModified\":\"2019-07-18T10:36:24+00:00\",\"author\":{\"@id\":\"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b\"},\"description\":\"SIBprima June 2018 - Patentability of antibodies for therapeutic use - Proposed SPC waiver - Italy implements EU Directive on trade secrets\",\"breadcrumb\":{\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.sib.it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"(English) SIBprima June 2018 &#8211; Patenting antibodies for therapeutic use &#8211; Proposed SPC waiver &#8211; Italy implements trade secrets Directive\"}]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b\",\"name\":\"Laura Ercoli\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\/\/www.sib.it\/#personlogo\",\"inLanguage\":\"en-US\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g\",\"caption\":\"Laura Ercoli\"},\"url\":\"https:\/\/www.sib.it\/en\/author\/lercoli\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"SIBprima June 2018 Patentability of antibodies for therapeutic use","description":"SIBprima June 2018 - Patentability of antibodies for therapeutic use - Proposed SPC waiver - Italy implements EU Directive on trade secrets","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/","og_locale":"en_US","og_type":"article","og_title":"SIBprima June 2018 Patentability of antibodies for therapeutic use","og_description":"SIBprima June 2018 - Patentability of antibodies for therapeutic use - Proposed SPC waiver - Italy implements EU Directive on trade secrets","og_url":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/","article_published_time":"2018-06-25T09:29:53+00:00","article_modified_time":"2019-07-18T10:36:24+00:00","og_image":[{"width":263,"height":165,"url":"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina-thumb2.png","type":"image\/png"}],"twitter_card":"summary","twitter_misc":{"Written by":"Laura Ercoli","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebSite","@id":"https:\/\/www.sib.it\/#website","url":"https:\/\/www.sib.it\/","name":"","description":"Intellectual Property since 1882","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.sib.it\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"ImageObject","@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#primaryimage","inLanguage":"en-US","url":"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina-thumb2.png","contentUrl":"https:\/\/www.sib.it\/wp-content\/uploads\/2018\/06\/copertina-thumb2.png","width":263,"height":165},{"@type":"WebPage","@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#webpage","url":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/","name":"SIBprima June 2018 Patentability of antibodies for therapeutic use","isPartOf":{"@id":"https:\/\/www.sib.it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#primaryimage"},"datePublished":"2018-06-25T09:29:53+00:00","dateModified":"2019-07-18T10:36:24+00:00","author":{"@id":"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b"},"description":"SIBprima June 2018 - Patentability of antibodies for therapeutic use - Proposed SPC waiver - Italy implements EU Directive on trade secrets","breadcrumb":{"@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.sib.it\/newsletter\/english-sibprima-june-2018\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.sib.it\/"},{"@type":"ListItem","position":2,"name":"(English) SIBprima June 2018 &#8211; Patenting antibodies for therapeutic use &#8211; Proposed SPC waiver &#8211; Italy implements trade secrets Directive"}]},{"@type":"Person","@id":"https:\/\/www.sib.it\/#\/schema\/person\/3988cde84153da4b745510f0712d395b","name":"Laura Ercoli","image":{"@type":"ImageObject","@id":"https:\/\/www.sib.it\/#personlogo","inLanguage":"en-US","url":"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/40352aead1e319e41371a554b61ab9b8?s=96&d=mm&r=g","caption":"Laura Ercoli"},"url":"https:\/\/www.sib.it\/en\/author\/lercoli\/"}]}},"_links":{"self":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/7038"}],"collection":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/comments?post=7038"}],"version-history":[{"count":24,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/7038\/revisions"}],"predecessor-version":[{"id":10447,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/posts\/7038\/revisions\/10447"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/media\/7103"}],"wp:attachment":[{"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/media?parent=7038"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/categories?post=7038"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.sib.it\/en\/wp-json\/wp\/v2\/tags?post=7038"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}